Technical Resources

  Poster Publications

Respiratory Viral Infections
Emerging requirements for infectious disease IVD quality control material
Human Papillomavirus (HPV) Infections
Cross-Platform High-Risk (hr) Low Occurrence HPV NAAT Positive Samples of Use in Nucleic Acid Detection Testing as Prospective External Quality Assessment Samples and User Defined Quality Controls
Abbott: Evaluation of Commercially Available HPV Panels with the Alinity m HR HPV Investigational Use Only (IUO) Assay
Abbott: Performance Characteristics of the Alinity m HR HPV Investigational Use Only (IUO) Assay and Comparison to the Cobas HPV 6800 Assay
Evaluating Diagnostic Workflows for HPV -Positive Oropharyngeal Squamous Cell Carcinoma Detection Using Simulated Specimens Mounted on Slides
Novel Cross-Platform High-Risk (hr) HPV NAAT Positive Controls for Use in L1 and E6/E7 Targeted Nucleic ACID (DNA and RNA) Detection Methods
Performance of full and extended genotyping assays using a new high-risk HPV multiplex panel
Sexually Transmitted Infections (STIs)
Mycoplasma genitalium, Drug Resistance, Nucleic Acid Detection; Introducing a New External Quality Assessment Scheme
Novel Mycoplasma genitalium (Mgen) and AMR Mgen A2059G Materials for use in a Cross-Platform NAAT Quality Control
Performance of NAAT that detect MGEN using Swab Quality Controls
Evaluating the Performance of Emerging STI Point of Care Assays Using Novel, Room Temperature Stable CT/NG/TV/MG Positive Swab Quality Control Materials
SARS Complete Infections
Simulated swab specimens for whole workflow quality control of SARS-CoV-2 molecular diagnostic testing
Advanced SARS-CoV-2 Variants of Concern (VOC) whole-genome materials for use as verification, external quality assessment (EQA) and prospective quality control samples
Advanced SARS-CoV-2 nucleocapsid protein swab-based formulation for use as a cross-platform EQA sample and as a prospective Quality Control
Novel neutralizing anti-S1 SARS-CoV-2 human monoclonal antibody formulation for use as a cross-platform EQA sample and prospective quality controls
Novel SARS-CoV-2 Full-Genome Material for Use in a Swab-Based Formulation as a Multi-Platform NAAT Quality Control
Respiratory virus multiplex formulations desiccated on Copan’s FLOQSwab® for use as cross-platform compatible EQA samples and laboratory Quality Control
Hepatitis C
Novel Hepatitis C Virus External Quality Control That Is Stable at Ambient Temperature And Suitable For Use In Low-Resource Settings
Gastrointestinal Infections
New External Quality Assessment Program for Laboratories that Detect H. pylori and Antimicrobial Resistant Markers Using Nucleic Acid Amplification Test Methods
Gential Ulcer Infections
FFPE HSV-1 and HSV-2 simulated tissue sections mounted on slides for use as prospective quality controls in IHC and qPCR workflows

  White Papers

High-Risk HPV Quality Controls are Needed to Uphold Clinical Laboratory Quality Standards
Expected stability of REDx™FLOQ® SARS-CoV-2 Swab Positive Control and REDx™FLOQ® SARS-CoV-2 Swab Negative Control in various sample transport media and storage conditions
Use of REDx™FLOQ® SARS-CoV-2 Ag Swab Positive Control and REDx™FLOQ® Respiratory Swab Negative Control as Quality Control by POC devices in various testing conditions
Expected stability of REDx™FLOQ® SARS-CoV-2 Swab Positive Control and REDx™FLOQ® SARS-CoV-2 Swab Negative Control in various sample transport media and storage conditions.